+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID07475949

Intravenous Tenecteplase Treatment for Acute Ischemic Stroke with Unknown Onset Time Using Non-Contrast CT A Multicenter Randomized Trial

Led by First Affiliated Hospital of Guangxi Medical University · Updated on 2026-09-30

352

Participants Needed

15

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of intravenous tenecteplase for treating acute ischemic stroke when the exact time of stroke onset is unknown, such as in wake-up stroke cases. This phase 3, multicenter, randomized trial aims to determine the safety and effectiveness of tenecteplase compared to standard medical treatment using non-contrast CT for patient selection. The main goal is to assess excellent patient outcomes based on functional status 90 days after treatment. Participants will be randomly assigned to one of two groups one group receives intravenous tenecteplase at a dose of 0.25 mgkg up to 25 mg plus standard medical care, and the other group receives standard medical care alone without thrombolysis. Tenecteplase is given as a single intravenous bolus soon after randomization. Standard medical treatment includes therapies such as antiplatelets, anticoagulants, blood pressure, and cholesterol management according to local guidelines. During the study, participants will be monitored and evaluated with assessments including neurological scales, disability scores, and quality of life questionnaires at various time points up to 90 days. The primary measure is an excellent outcome based on the modified Rankin Scale at about 3 months. Safety and functional improvements will also be tracked through clinical evaluations and imaging. The entire participation lasts until the 90-day assessment after treatment.

CONDITIONS

Brief Title

Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging

Research Team

D

Dong Pan, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here